Category: Herbs & Ingredients
Ginseng modestly lowers fasting blood glucose in some trials, which is why reviewing bodies list diabetes medicines among its interaction cautions. The evidence is limited and inconsistent, and the concern is additive rather than proven. This article sets out what to ask before combining them.
Category: Herbs and Ingredients | Reading time: ~12 min | Level: Intermediate
Ginseng is bought for energy and stamina, not for blood sugar. But if you manage diabetes with medication, the two questions overlap more than the marketing suggests. A medicine whose entire job is to lower blood glucose, plus a botanical that several trials suggest also nudges glucose down, can in principle stack. Stacking two glucose-lowering effects is exactly how a well controlled number drifts into a low.
This is a quiet, additive concern rather than a dramatic one, and the evidence underneath it is genuinely modest. No landmark trial has put ginseng on top of metformin or insulin and measured what happens. What exists is a real, if small and inconsistent, glucose-lowering signal from ginseng on its own, and that is enough to make this a conversation with your diabetes team before it is a purchase.
One thing to be clear about from the start. The interaction described here is drawn from the published clinical literature and regulatory evidence reviews. It is not a claim manufactured by any single product or platform, and the studies behind it are named below so you can look them up yourself.
This article covers Panax ginseng, also called Asian, Korean or red ginseng, the root used in most ginseng supplements sold in Europe and the UK. Its active compounds are ginsenosides, a family of plant chemicals thought to influence how the body handles glucose, among other actions [1][2].
Several trials have measured ginseng's effect on blood sugar directly. A meta-analysis of 16 trials found that ginseng produced a modest but statistically significant reduction in fasting blood glucose, though it found no significant overall effect on fasting insulin, HbA1c or insulin resistance [3]. That is the mechanism behind this interaction in plain terms: ginseng appears to nudge fasting glucose down a little, and a drug designed to do the same thing, taken alongside it, could in theory push it down further than intended. The US National Center for Complementary and Integrative Health describes the overall evidence on ginseng and blood sugar as "overall inconclusive and conflicting," which is an honest way of saying the signal is real in some trials, absent in others, and never large [1].
It matters which species you are looking at. Panax ginseng and American ginseng, Panax quinquefolius, are different plants with different evidence bases, and the two are frequently confused on generic packaging. The glucose and warfarin research most often cited for "ginseng" was actually conducted on American ginseng, a point covered in detail further down this article [4].
The clearest data point is the 16 trial meta-analysis already mentioned: a mean reduction in fasting blood glucose of 0.31 mmol/L compared with control, a real effect, but a modest one [3]. The same analysis found no significant change in fasting insulin, HbA1c or a standard measure of insulin resistance across the trials as a whole, meaning the glucose effect did not clearly translate into the broader markers doctors use to judge diabetes control [3]. Europe's regulator, the EMA, has never granted Panax ginseng a well established use indication for blood sugar or for any condition. Its only registered use is a traditional use indication for fatigue and weakness, based on long standing use rather than clinical trial proof [2]. That regulatory silence on diabetes is itself informative: it tells you the evidence has not reached the bar regulators use for a specific medical claim, even though a genuine pharmacological signal exists underneath it.
Reviewing bodies list diabetes medicines among ginseng's interaction cautions not because a landmark trial proved harm, but because the mechanism is plausible and the downside of an unmonitored low blood sugar episode is serious enough to warrant caution on modest evidence. This is standard practice in herb-drug interaction guidance: a real, even if small, pharmacological effect in the same direction as a medicine's intended action is treated as an additive risk worth flagging, whether or not anyone has run the specific combination through a trial [1].
Ginseng is also frequently listed as an interaction concern for warfarin, and this is worth a brief, honest detour because it illustrates how easily species get blurred in supplement guidance. The RCT most often cited for ginseng reducing warfarin's anticoagulant effect used American ginseng, not Panax ginseng: a crossover trial found American ginseng significantly lowered peak INR compared with placebo [4]. For Panax ginseng specifically, the species this article covers, two separate controlled trials found no significant effect on warfarin's pharmacokinetics or pharmacodynamics [5]. A herb-drug interaction review still lists warfarin among ginseng's documented cautions in general terms, and because warfarin has such a narrow safety margin, disclosure and monitoring remain sensible regardless of species [6]. But if you see a claim that "ginseng lowers warfarin's effect," the trial evidence behind that specific claim belongs to American ginseng, not the Panax ginseng covered here.
Ginseng's most common side effect in the evidence reviews is insomnia, alongside gastrointestinal upset and, at high doses, a stimulant-like pattern sometimes called ginseng abuse syndrome, involving insomnia, irritability and raised blood pressure [1][2]. A case report describes mania developing when ginseng was combined with the older antidepressant phenelzine, a monoamine oxidase inhibitor, a serious though isolated signal [6]. Ginseng is not thought to cause direct liver injury, but it has been linked to herb-drug interactions through effects on liver metabolising enzymes that can indirectly contribute to adverse events [7].
| Combination | What the evidence shows | Practical caution | |---|---|---| | Ginseng with metformin | Ginseng modestly lowers fasting glucose in trials [3]; metformin rarely causes hypoglycaemia alone. | Low added risk, but mention it to your diabetes team and watch readings for the first fortnight. | | Ginseng with a sulfonylurea (for example gliclazide) | Sulfonylureas can already cause low blood sugar on their own; an additive glucose-lowering botanical raises that risk further. | Discuss before starting; monitor glucose more closely in the first two to three weeks. | | Ginseng with insulin | Insulin carries the clearest hypoglycaemia risk of any diabetes medicine; ginseng's modest glucose-lowering effect is additive on top of it. | Only with your diabetes team informed; more frequent monitoring; know the signs of a low. | | Ginseng with warfarin | The INR-lowering effect often attributed to "ginseng" was shown with American ginseng; two controlled trials of Panax ginseng found no warfarin interaction [4][5]. | Disclose regardless, since species on labels is not always precise; routine INR monitoring is sensible practice. | | Ginseng with an MAOI (for example phenelzine) | A case report describes mania when combined with phenelzine [6]. | Avoid without specialist psychiatric guidance. |
If you manage diabetes with medication, tell your prescriber or diabetes team before starting ginseng, or mention it at your next review if you already take it. This is not because ginseng is a proven danger; the trial evidence for its glucose effect is small and inconsistent. It is because the direction of that effect is the same direction as your medication, and additive effects are exactly the kind of thing monitoring exists to catch early rather than after a problem.
If a trial of ginseng is agreed, a sensible approach is to check glucose a little more often for the first two to three weeks, the rough window in which any effect would be expected to build. Learn the signs of hypoglycaemia, shakiness, sweating, a racing heart, confusion and hunger, and know how to treat a low quickly if one occurs.
Do not adjust your own diabetes medication because you started ginseng, and do not use ginseng as a substitute for prescribed treatment. If your readings genuinely change, that is a decision for your prescriber, made against measured numbers, not a self-directed adjustment.
If you take warfarin as well, mention that too, and be specific about which species of ginseng you are using if you know it, since the warfarin evidence differs meaningfully between Panax and American ginseng.
The honest grade here is limited, real evidence pointing in a consistent but modest direction, not a demonstrated danger. Ginseng lowers fasting blood glucose by a small amount in the best available meta-analysis, without a clear effect on the broader markers of diabetes control, and Europe's regulator has never approved it for blood sugar or any other specific indication. That is not nothing: a small, real glucose-lowering effect stacked on top of a medicine designed to do the same thing is a legitimate reason for monitoring. It is also not a reason for alarm, since no trial has shown a dangerous interaction, and the effect size involved is modest even on its own.
The theoretical additive effect is worth taking seriously enough to mention to a prescriber and to watch for with glucose monitoring. It is not evidence that ginseng is unsafe with diabetes medication in general, and it is certainly not a reason to treat ginseng as a replacement for treatment that has actually been proven to control blood sugar.
Ginseng sits in the PlantRx catalogue for energy and focus support, and its blood sugar caution is presented alongside that use rather than tucked into small print. Structure and function only: ginseng is offered to support energy and mental alertness; it is not a diabetes treatment, and it must not be used to self-manage blood sugar in place of prescribed medication.
If you are unsure whether your medication list makes ginseng a poor fit, Remy, the PlantRx assistant, can surface the published blood sugar and interaction cautions relevant to your situation and point you back to your prescriber or diabetes team for the calls that depend on your monitoring history.
Beyond the diabetes medication caution, a few other points belong in the same decision. Ginseng is not recommended in pregnancy or breastfeeding, where regulators state that safety has not been established and animal data have shown potential for harm [2][1]. It may worsen autoimmune conditions and is not recommended for under 18s [1][2]. Insomnia is its most commonly reported side effect, and high doses have been associated with a stimulant-like pattern of irritability and insomnia [1]. European guidance caps traditional use at up to three months, with a recommendation to see a doctor if symptoms persist beyond two weeks of use [2].
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
1. National Center for Complementary and Integrative Health (NCCIH). Asian Ginseng: Usefulness and Safety. Government evidence and safety review. nccih.nih.gov/health/asian-ginseng. 2. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Panax ginseng C.A.Mey., radix, Revision 1. EMA/HMPC/27744/2023, Final, adopted 29 May 2024. Regulatory herbal monograph; traditional use only, no well established use indication. 3. Shishtar E, Sievenpiper JL, Djedovic V, et al. (2014). The effect of ginseng (the genus panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials. PLOS ONE. Meta-analysis of 16 trials; fasting glucose reduced (mean difference minus 0.31 mmol/L), no significant effect on fasting insulin, HbA1c or HOMA-IR. 4. Yuan CS, Wei G, Dey L, et al. (2004). American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Annals of Internal Medicine. RCT in American ginseng (Panax quinquefolius), not the Panax ginseng species covered in this article. 5. Jiang X, Williams KM, Liauw WS, et al. (2004). Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. RCT crossover in Panax ginseng; no significant effect on warfarin pharmacokinetics or pharmacodynamics. 6. Chen XW, Sneed KB, Pan SY, et al. (2012). Herb-drug interactions and mechanistic and clinical considerations. Current Drug Metabolism. Review, cited for a case report of mania with the MAOI phenelzine and for general herb-drug interaction context. 7. National Institute of Diabetes and Digestive and Kidney Diseases, LiverTox. Ginseng (NBK548200). Government safety monograph, likelihood score E (unlikely direct cause of liver injury; interactions occur via effects on liver metabolising enzymes).
Not without checking with the clinician or team who manages your diabetes first. Ginseng has a modest, inconsistent glucose-lowering effect in trials, and reviewing bodies list diabetes medicines among its interaction cautions on that basis. Metformin rarely causes low blood sugar on its own, so the added risk is likely small, but it is still worth a conversation and a plan to check readings for the first couple of weeks.
Modestly, and not consistently. A meta-analysis of 16 trials found a small but statistically significant reduction in fasting blood glucose with ginseng, but no significant overall effect on fasting insulin, HbA1c or insulin resistance. The reviewing body NCCIH describes the overall blood sugar evidence as inconclusive and conflicting. It is a real signal, just a small and uneven one.
Insulin is the setting where the additive concern matters most, because insulin can already cause low blood sugar on its own, and a glucose-lowering botanical could add to that. This does not make the combination forbidden, but it does mean it should happen with your diabetes team informed and your glucose monitored more closely, not discovered after a hypo.
They are different species with different evidence bases. American ginseng (Panax quinquefolius) has the clearer glucose-lowering data in some trials and is also the species with the best documented warfarin interaction. Asian or Panax ginseng, the species covered in this article, has a smaller and more inconsistent glucose signal, and its warfarin data are actually reassuring rather than concerning. Checking which species a product contains matters more than the word "ginseng" on the label.
No. Ginseng's glucose-lowering effect is small, inconsistent across trials and not established as a reliable treatment. Reviewing bodies grade the evidence as limited, and no regulator has approved ginseng as a diabetes treatment. Stopping or reducing prescribed medication in favour of a supplement with this evidence profile is how blood sugar ends up poorly controlled.
Shakiness, sweating, a racing heart, hunger, irritability, confusion and difficulty concentrating, and in more severe cases drowsiness or loss of consciousness. Anyone on a medicine that can cause hypoglycaemia who adds ginseng should know these signs, carry fast-acting sugar, and tell their prescriber if episodes appear or become more frequent.
If there is an effect, trial evidence suggests it builds over weeks of regular use rather than appearing after a single dose. That is why the practical advice is to check glucose a little more often in the first two to three weeks of starting ginseng, so any change shows up as a trend on your meter rather than as a surprise low.
Well controlled means your medication is holding glucose in a target range, and a botanical with even a small glucose-lowering signal is one more variable in that balance. Even a short course is worth clearing with your diabetes team, ideally with a plan to test a little more often for the first couple of weeks. The cost of asking is a short conversation; the cost of not asking is an unexplained low you cannot account for.
That is not a decision to make from a supplement label. The evidence for ginseng's glucose effect is small and inconsistent across trials, and no study has tested it as a substitute for prescribed treatment. If your readings genuinely improved while taking ginseng, any change to your medication is a decision for your prescriber, based on measured results, not a self-directed reduction.
They are separate questions worth keeping apart. The diabetes caution concerns Panax ginseng's modest glucose-lowering effect. The warfarin question is different again: the well known INR-lowering effect linked to ginseng was shown with American ginseng, a different species, while two controlled trials of Panax ginseng specifically found no effect on warfarin. Mention both medications and the ginseng to your prescriber regardless, since species labelling on supplements is not always precise.